Company Filing History:
1 out of 96 
1 out of 181 
Years Active: 2024
Title: The Innovations of Mei-Ling Hou
Introduction
Mei-Ling Hou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing diseases related to neurotensin receptor 1 (NTSR1) activity.
Latest Patents
Mei-Ling Hou holds 1 patent for his invention titled "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, it includes a method or kit for detecting NTSR1 in a sample.
Career Highlights
Throughout his career, Mei-Ling Hou has worked with notable organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His expertise in biotechnology has allowed him to contribute to advancements in medical research and therapeutic development.
Collaborations
Mei-Ling has collaborated with esteemed colleagues, including Cheng-Chou Yu and Shu-Ping Yeh. Their joint efforts have furthered research in the field and enhanced the understanding of NTSR1-related disorders.
Conclusion
Mei-Ling Hou's innovative work in developing humanized antibodies represents a significant advancement in biotechnology. His contributions have the potential to impact the treatment of various diseases, showcasing the importance of research and collaboration in the field.